• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Insights and Challenges From the Current Study.

作者信息

Cho Min-Jung

机构信息

Department of Pediatrics, Gyeongsang National University Changwon Hospital, Changwon, Korea.

出版信息

Korean Circ J. 2024 Dec;54(12):865-867. doi: 10.4070/kcj.2024.0417.

DOI:10.4070/kcj.2024.0417
PMID:39733779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11685348/
Abstract
摘要

相似文献

1
Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Insights and Challenges From the Current Study.儿童儿茶酚胺能多形性室性心动过速：当前研究的见解与挑战
Korean Circ J. 2024 Dec;54(12):865-867. doi: 10.4070/kcj.2024.0417.
2
A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.兰尼碱受体2（RyR2）中的一种新型变异导致家族性儿茶酚胺能多形性室性心动过速。
Forensic Sci Int. 2017 Jan;270:173-177. doi: 10.1016/j.forsciint.2016.12.001. Epub 2016 Dec 9.
3
Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated.儿茶酚胺敏感性多形性室性心动过速：肾上腺素禁忌的心脏骤停。
Pediatr Crit Care Med. 2019 Mar;20(3):262-268. doi: 10.1097/PCC.0000000000001847.
4
Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.一名患有睡眠和运动期间有症状的儿茶酚胺能多形性室性心动过速的青少年患者中一种新型兰尼碱受体2（RyR2）突变的描述：病例报告
J Med Case Rep. 2018 Oct 9;12(1):298. doi: 10.1186/s13256-018-1825-6.
5
Clinical and genetic characteristics of catecholaminergic polymorphic ventricular tachycardia combined with left ventricular non-compaction.儿茶酚胺多形性室性心动过速合并左室致密化不全的临床和遗传学特征。
Cardiol Young. 2024 May;34(5):1010-1017. doi: 10.1017/S1047951123003086. Epub 2023 Nov 29.
6
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.儿童儿茶酚胺能多形性室性心动过速：来自一项国际多中心注册研究的治疗策略与结果分析
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):633-42. doi: 10.1161/CIRCEP.114.002217. Epub 2015 Feb 24.
7
Catecholaminergic Polymorphic Ventricular Tachycardia: Advancing From Molecular Insights to Preclinical Models.儿茶酚胺能多形性室性心动过速：从分子见解到临床前模型的进展
J Am Heart Assoc. 2025 Mar 18;14(6):e038308. doi: 10.1161/JAHA.124.038308. Epub 2025 Mar 13.
8
Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia.房室结消融术在儿茶酚胺敏感性多形性室性心动过速中不是一种有效的治疗策略。
Tex Heart Inst J. 2023 May 1;50(3). doi: 10.14503/THIJ-22-7974.
9
Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.青少年在亚甲二氧基甲基苯丙胺和大麻诱发心脏骤停后出现儿茶酚胺多形性室性心动过速。
Crit Care Med. 2012 Jul;40(7):2223-6. doi: 10.1097/CCM.0b013e318250a870.
10
Catecholaminergic polymorphic ventricular tachycardia: An exciting new era.儿茶酚胺能多形性室性心动过速：一个令人兴奋的新时代。
Ann Pediatr Cardiol. 2016 May-Aug;9(2):137-46. doi: 10.4103/0974-2069.180645.

本文引用的文献

1
Treatment Outcomes in Children With Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Institutional Experience.儿茶酚胺能多形性室性心动过速患儿的治疗结果：单机构经验
Korean Circ J. 2024 Dec;54(12):853-864. doi: 10.4070/kcj.2024.0183.
2
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.一项针对儿茶酚胺多形性室性心动过速症状性儿童的植入型心脏复律除颤器治疗的国际多中心队列研究。
Heart Rhythm. 2024 Oct;21(10):1767-1776. doi: 10.1016/j.hrthm.2024.04.006. Epub 2024 Apr 7.
3
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
4
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.在因心搏骤停而复苏的儿茶酚胺多形性室性心动过速的既往未诊断患者中植入心脏复律除颤器。
Eur Heart J. 2019 Sep 14;40(35):2953-2961. doi: 10.1093/eurheartj/ehz309.
5
Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia.将心脏与大脑联系起来：儿茶酚胺多形性室性心动过速患者的神经发育障碍。
Heart Rhythm. 2019 Feb;16(2):220-228. doi: 10.1016/j.hrthm.2018.08.025. Epub 2018 Aug 28.
6
Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.植入型心律转复除颤器在儿茶酚胺多形性室性心动过速中的应用：一项系统评价。
Heart Rhythm. 2018 Dec;15(12):1791-1799. doi: 10.1016/j.hrthm.2018.06.046. Epub 2018 Jul 3.
7
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).心律协会（HRS）和欧洲心律协会（EHRA）关于通道病和心肌病基因检测现状的专家共识声明：本文件是由心律协会（HRS）与欧洲心律协会（EHRA）合作制定的。
Europace. 2011 Aug;13(8):1077-109. doi: 10.1093/europace/eur245.